Early Feeding Following Percutaneous Gastrostomy Tube Placement

NCT ID: NCT03319576

Last Updated: 2019-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-30

Study Completion Date

2019-10-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study plans to learn more about the safety of early feeding following placement of a feeding tube. Doctors in other specialties feed patients 4 hours after patients receive a feeding tube. However, Interventional Radiologists typically wait to feed patients for 24 hours following feeding tube placement. The investigator would like to demonstrate that feeding after 4 hours does not increase complications and can actually reduce the burden to patients who receive a feeding tube.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early feeding

Patients randomized to early feeding will be fed 4 hours following gastrostomy tube placement

Group Type EXPERIMENTAL

Feeding at 4 hours

Intervention Type OTHER

Patients will be fed 4 hours after their gastrostomy tube placement procedure.

Standard feeding

Patients randomized to standard feeding will be fed 24 hours following gastrostomy tube placement

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Feeding at 4 hours

Patients will be fed 4 hours after their gastrostomy tube placement procedure.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients between the ages of 18-80 years
* Outpatients receiving a gastrostomy tube at University of Colorado that do not require post-pyloric feeding
* Patients that have no contraindication for intragastric feeding immediately following tube placement
* INR (international normalized ratio) \<1.5
* Platelet count \> 50,000/µL
* WBC (white blood cell count) 4.0-11.1 x 109/L

Exclusion Criteria

* Patients \< 18 years or \> 80 years of age
* Patients admitted to the hospital at the time of screening (i.e., inpatients)
* Women who are pregnant (confirmed by urine pregnancy screen)
* Patients requiring post-pyloric feeding
* Patients receiving venting gastrostomy tubes
* Patients receiving primary Gastro-Jejunal (GJ) Tube tube placement
* Patients with an interposed bowel on CT after stomach insufflation
* INR \> 1.5
* Platelet count \< 50,000/µL
* WBC \> 11.1 x 109/L
* Known active infection
* Need for post-gastric feeding
* History of gastric bypass surgery or Roux-En-Y
* Mechanical obstruction of the GI tract
* Active peritonitis
* Known hemodynamic instability as demonstrated by tachycardia, hypotension, labile blood pressure or altered mental status.
* Bowel ischemia
* Ascites
* Recent Gastro-Intestinal (GI) bleeding (within 2 weeks)
* Respiratory compromise as demonstrated by hypercarbia (CO2\>45mmHg) or hypoxia (O2\<90%)
* Unable to provide informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Premal Trivedi, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado, Denver

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Colorado

Aurora, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-1074

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Legume Diet Satiety Pilot Study
NCT02269631 COMPLETED NA